-
-
-
-
-
-
-
Pacira BioSciences stockholders elect all three director nominees
-
-
-
-
-
-
-
Pacira BioSciences urges stockholders to support board nominees
-
-
-
-
-
-
-
Pacira Pharma (PCRX) Misses Q4 EPS by 33c ; Offers Guidance
-
-
-
-
-
-
-
Pacira Pharma (PCRX) Tops Q3 EPS by 5c ; Offers Guidance
-
-
-
-
-
-
-
Pacira BioSciences partners with J&J MedTech to expand ZILRETTA reach
-
-
-
-
-
-
-
DOMA Perpetual Supports Pacira's (PCRX) New $300M Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders
-
-
-
-
-
-
-
Pacira BioSciences (PCRX) Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
-
452,875 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

